Page last updated: 2024-10-30

metformin and Brain Disorders

metformin has been researched along with Brain Disorders in 13 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Metformin was withheld and signs and symptoms quickly resolved."1.48Metformin-induced encephalopathy: the role of thiamine. ( Bynevelt, M; Franconi, C; McGarvey, C; Prentice, D, 2018)
"Metformin was immediately stopped, and regular hemodialysis was conducted."1.39Two additional cases of metformin-associated encephalopathy in patients with end-stage renal disease undergoing hemodialysis. ( Bae, EJ; Chang, SH; Cho, HS; Jeon, DH; Kang, YJ; Kim, HJ; Park, DJ; Seo, JW, 2013)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (15.38)29.6817
2010's7 (53.85)24.3611
2020's4 (30.77)2.80

Authors

AuthorsStudies
Li, JX1
Li, Z1
Jin, W1
Wang, TJ1
Guo, QZ1
Fan, MY1
Berrada, M1
Benkirane, N1
El Moutawakil, B1
Rafai, MA1
El Otmani, H1
Hasan, HF1
Rashed, LA1
El Bakary, NM1
Chang, YA1
Tarng, DC1
Yang, CY1
McGarvey, C1
Franconi, C1
Prentice, D1
Bynevelt, M1
Fernandes, GC2
Koltermann, T2
Campos, L2
Vedolin, L2
Rieder, CR2
BĂ©jot, Y1
Bielefeld, P1
Guiboux, AL1
Sgro, C1
Janoura, S1
Devilliers, H1
Besancenot, JF1
Giroud, M1
Kaiwar, C1
Pandey, S1
Garabadu, D1
Jung, EY1
Cho, HS2
Seo, JW2
Kim, DW1
Kim, HJ2
Chang, SH2
Park, DJ2
Kang, YJ1
Bae, EJ1
Jeon, DH1
Vander, T1
Hallevy, H1
Ifergane, G1
Herishanu, YO1

Other Studies

13 other studies available for metformin and Brain Disorders

ArticleYear
Hypoglycemic encephalopathy caused by overdose of metformin in an adolescent.
    Chinese medical journal, 2020, Jan-05, Volume: 133, Issue:1

    Topics: Adolescent; Brain Diseases; Female; Humans; Hypoglycemia; Metformin

2020
An MRI pattern of metformin-associated encephalopathy in hemodialysis.
    Revue neurologique, 2021, Volume: 177, Issue:3

    Topics: Brain Diseases; Humans; Hypoglycemic Agents; Magnetic Resonance Imaging; Metformin; Renal Dialysis

2021
Concerted outcome of metformin and low dose of radiation in modulation of cisplatin induced uremic encephalopathy via renal and neural preservation.
    Life sciences, 2021, Jul-01, Volume: 276

    Topics: Animals; Antineoplastic Agents; Biomarkers; Brain Diseases; Cisplatin; Dose-Response Relationship, R

2021
Lentiform fork sign in a uremic patient after inadvertent exposure to metformin.
    Clinical toxicology (Philadelphia, Pa.), 2022, Volume: 60, Issue:3

    Topics: Brain Diseases; Female; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Metformin; Midd

2022
Metformin-induced encephalopathy: the role of thiamine.
    Internal medicine journal, 2018, Volume: 48, Issue:2

    Topics: Adult; Brain Diseases; Diabetic Nephropathies; Female; Humans; Hypoglycemic Agents; Metformin; Thiam

2018
Teaching NeuroImages: the lentiform fork sign: an MRI pattern of metformin-associated encephalopathy.
    Neurology, 2015, Jan-20, Volume: 84, Issue:3

    Topics: Brain Diseases; Corpus Striatum; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Mag

2015
Recurrent encephalopathy induced by metformin in an elderly man.
    Journal of the American Geriatrics Society, 2015, Volume: 63, Issue:3

    Topics: Aged; Brain Diseases; Humans; Male; Metformin; Recurrence

2015
Teaching NeuroImages: The lentiform fork sign: An MRI pattern of metformin-associated encephalopathy.
    Neurology, 2015, Aug-18, Volume: 85, Issue:7

    Topics: Brain Diseases; Corpus Striatum; Female; Humans; Hypoglycemic Agents; Magnetic Resonance Imaging; Me

2015
Author Response.
    Neurology, 2015, Aug-18, Volume: 85, Issue:7

    Topics: Brain Diseases; Corpus Striatum; Female; Humans; Hypoglycemic Agents; Magnetic Resonance Imaging; Me

2015
Piracetam Facilitates the Anti-Amnesic but not Anti-Diabetic Activity of Metformin in Experimentally Induced Type-2 Diabetic Encephalopathic Rats.
    Cellular and molecular neurobiology, 2017, Volume: 37, Issue:5

    Topics: Amnesia; Animals; Blood Glucose; Brain Diseases; Brain-Derived Neurotrophic Factor; Choline; Diabete

2017
Metformin-induced encephalopathy without lactic acidosis in a patient with contraindication for metformin.
    Hemodialysis international. International Symposium on Home Hemodialysis, 2009, Volume: 13, Issue:2

    Topics: Acidosis, Lactic; Brain Diseases; Contraindications; Diabetes Mellitus, Type 1; Diabetic Nephropathi

2009
Two additional cases of metformin-associated encephalopathy in patients with end-stage renal disease undergoing hemodialysis.
    Hemodialysis international. International Symposium on Home Hemodialysis, 2013, Volume: 17, Issue:1

    Topics: Brain Diseases; Contraindications; Female; Humans; Hypoglycemic Agents; Kidney Failure, Chronic; Mag

2013
Metformin-induced encephalopathy without lactic acidosis.
    Diabetic medicine : a journal of the British Diabetic Association, 2004, Volume: 21, Issue:2

    Topics: Acidosis, Lactic; Aged; Brain Diseases; Diabetes Mellitus; Humans; Hypoglycemic Agents; Male; Metfor

2004